Novel cancer drug delivery system improves Paclitaxel absorption
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Jun-2026 14:16 ET (23-Jun-2026 18:16 GMT/UTC)
Women are more likely to survive cancer than men but face a higher risk of serious and adverse side effects from treatment, according to a landmark international study from Adelaide University.
Published in the Journal of the National Cancer Institute (JNCI) and conducted in partnership with a international collaborators, the research identified consistent differences between male and female cancer patients in both survival and treatment toxicity.
Female patients had a 21% lower risk of death compared with male patients, yet a 12% higher risk of severe toxicities.
One in ten emergency patients with visible blood in their urine die within three months of presenting at A&E, new research has found. The WASHOUT study, presented at the European Association of Urology Congress (EAU26) in London, found that a scan within 48 hours could reduce this risk.
Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.
Timing is critical in diagnosing diseases such as cancer. Researchers within The Grainger College of Engineering at the University of Illinois Urbana-Champaign used a historically underappreciated tiny powerhouse to detect diseases sooner.
Engineers at Duke University have demonstrated a technique that uses microbubbles and ultrasound to help relatively large cancer drugs enter tumor cells and cause them to self-destruct.
CD4+ T cells, long regarded as supporting actors in cancer immunity, are emerging as central regulators of tumor control and immune resistance.